Direct actions of the luteinizing hormone-releasing hormone agonist, deslorelin, on anterior pituitary contents of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), LH and FSH subunit messenger ribonucleic acid, and plasma concentrations of LH and FSH in castrated male cattle

被引:26
|
作者
Aspden, WJ
Rao, A
Scott, PT
Clarke, IJ
Trigg, TE
Walsh, J
DOcchio, MJ
机构
[1] CSIRO,DIV TROP ANIM PROD,TROP BEEF CTR,ROCKHAMPTON,QLD 4702,AUSTRALIA
[2] UNIV CENT QUEENSLAND,DEPT BIOL,ROCKHAMPTON,QLD 4702,AUSTRALIA
[3] PRINCE HENRYS INST MED RES,MELBOURNE,VIC 3168,AUSTRALIA
[4] PEPTECH ANIM HLTH PTY LTD,DEE WHY,NSW 2099,AUSTRALIA
关键词
D O I
10.1095/biolreprod55.2.386
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The objective in this study was to characterize direct effects of the LHRH agonist, deslorelin, on anterior pituitary gland function in male cattle in the absence of gonadal feedback. Castrated bulls (steers), 30 mo old, were allocated to four groups: group 1, control, no treatment (n = 8); group 2, five deslorelin implants (similar to 250 mu g total deslorelin/day) for 42 days (n = 8); group 3, control + LHRH (50 mu g i.m.) at weekly intervals (n = 3); group 4, five deslorelin implants + LHRH as for group 3 (n = 3). Plasma LH was similar (p > 0.05) for steers in groups 1 and 2 on Day 0 and lower (p < 0.05) for steers in group 2 on Day 4, and continued to decrease to Day 41 (group 1, 1.71 +/- 0.20 ng/ml [mean +/- SEM]; group 2, 0.38 +/- 0.03 ng/ml [p < 0.001]). Mean plasma concentrations of FSH were similar (p > 0.05) for steers in groups 1 and 2 on Day 0 and lower (p < 0.05) for steers in group 2 on Day 7, and declined to Day 41 (group 1, 43.5 +/- 3.9 ng/ml; group 2, 17.5 +/- 1.5 ng/ml [p < 0.001]). Steers in group 3 showed increases in plasma LH after injection of LHRH on all occasions, while steers in group 4 did not show increases in plasma LH from Day 14 onward. Mean relative pituitary contents (arbitrary units) of LH beta- and FSH beta-subunit mRNAs were reduced on Day 42 in steers treated with deslorelin (LH beta: groups 1 and 3, 1.56 +/- 0.27; groups 2 and 4, 0.08 +/- 0.01 [p < 0.001]; FSH beta: groups 1 and 3, 1.01 +/- 0.08; groups 2 and 4, 0.34 +/- 0.07 [p < 0.001]). However, alpha-subunit mRNA was similar for control steers and steers treated with deslorelin (groups 1 and 3, 1.00 +/- 0.11; groups 2 and 4, 0.86 +/- 0.12 [p > 0.1]). Pituitary content of LH, but not FSH, was reduced in steers treated with deslorelin. In summary, steers treated with deslorelin showed desensitization to natural LHRH, and this was associated with reduced pituitary contents of LH and FSH beta-subunit mRNAs, a reduction in pituitary content of LH, and decreases in plasma concentrations of LH and FSH. This demonstrated, for the first time, a direct action of LHRH agonist on LH and FSH beta-subunit gene expression in cattle, independent of gonadal feedback. Also, there was a differential effect of treatment with deslorelin on gonadotropin alpha- and beta-subunit mRNA contents in the anterior pituitary.
引用
收藏
页码:386 / 392
页数:7
相关论文
共 50 条
  • [21] PITUITARY LUTEINIZING-HORMONE (LH), FOLLICLE-STIMULATING HORMONE (FSH) AND PROLACTIN FROM BIRTH TO PUBERTY IN FEMALE AND MALE RATS
    DOHLER, KD
    MUHLEN, AVZ
    DOHLER, U
    ACTA ENDOCRINOLOGICA, 1977, 85 (04): : 718 - 728
  • [22] DIFFERENTIAL EFFECT OF GLUCOCORTICOIDS ON SYNTHESIS AND SECRETION OF LUTEINIZING-HORMONE (LH) AND FOLLICLE-STIMULATING HORMONE (FSH)
    RINGSTROM, SJ
    SCHWARTZ, NB
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 27 (1-3): : 625 - 630
  • [23] RADIOIMMUNOASSAY OF LUTEINIZING HORMONE (LH) AND FOLLICLE-STIMULATING HORMONE (FSH) IN NORMAL CHILDREN AND VARIOUS ABNORMAL CONDITIONS
    KENNY, FM
    MIDGLEY, AR
    JAFFE, RB
    GARCES, LY
    VAZQUEZ, A
    JOURNAL OF PEDIATRICS, 1968, 72 (04): : 565 - +
  • [24] Medaka follicle-stimulating hormone (Fsh) and luteinizing hormone (Lh): Developmental profiles of pituitary protein and gene expression levels
    Burow, Susann
    Fontaine, Romain
    von Krogh, Kristine
    Mayer, Ian
    Nourizadeh-Lillabadi, Rasoul
    Hollander-Cohen, Lian
    Cohen, Yaron
    Shpilman, Michal
    Levavi-Sivan, Berta
    Weltzien, Finn-Arne
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2019, 272 : 93 - 108
  • [25] SERUM LUTEINIZING HORMONE (LH) AND FOLLICLE-STIMULATING HORMONE (FSH) CONCENTRATIONS IN SUBJECTS WITH SICKLE-CELL ANEMIA (SCA)
    PENNY, R
    OLAMBIWONNU, NO
    FRASIER, SD
    PEDIATRIC RESEARCH, 1974, 8 (04) : 407 - 407
  • [26] SUPPRESSION OF URINARY EXCRETION OF LUTEINIZING HORMONE (LH) AND FOLLICLE STIMULATING HORMONE (FSH) BY MEDROXYPROGESTERONE ACETATE
    RIFKIND, AB
    KULIN, HE
    CARGILLE, CM
    RAYFORD, PC
    ROSS, GT
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1969, 29 (04): : 506 - +
  • [27] Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)
    S Davies
    C M R Bax
    E Chatzaki
    T Chard
    R K Iles
    British Journal of Cancer, 2000, 83 : 1730 - 1734
  • [28] Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)
    Davies, S
    Bax, CMR
    Chatzaki, E
    Chard, T
    Iles, RK
    BRITISH JOURNAL OF CANCER, 2000, 83 (12) : 1730 - 1734
  • [29] FOLLICLE-STIMULATING HORMONE-RELEASING FACTOR (FSH-RF) AND LUTEINIZING HORMONE-RELEASING FACTOR (LH-RF) IN RAT HYPOTHALAMIC EXTRACT
    KOBAYASHI, T
    KOBAYASH.T
    KIGAWA, T
    MIZUNO, M
    AMENOMORI, Y
    WATANABE, T
    ICHIKAWA, H
    ENDOCRINOLOGIA JAPONICA, 1967, 14 (02): : 101 - +
  • [30] SERUM LH IN EWES TREATED WITH SYNTHETIC LUTEINIZING HORMONE-RELEASING HORMONE-FOLLICLE STIMULATING HORMONE-RELEASING HORMONE (LH-RH/FSH-RH) AT 3 PERIODS OF ANESTRUS
    REEVES, JJ
    TARNAVSKY, GK
    CHAKRABORTY, PK
    JOURNAL OF ANIMAL SCIENCE, 1974, 38 (02) : 369 - 373